Newsroom
Sorted by: Latest
-
Riassunto: SBC Medical annuncia i risultati finanziari del quarto trimestre e dell'intero esercizio 2025
IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" o l'"Azienda"), un'organizzazione di servizi di gestione che opera in un ampio ventaglio di attività di franchising in diversi campi medici, ha annunciato oggi i propri risultati finanziari per il quarto trimestre dell'esercizio fiscale 2025 (i tre mesi conclusisi il 31 dicembre 2025) e per l'intero esercizio fiscale 2025 (i dodici mesi conclusisi il 31 dicembre 2025). Punti salienti del qu...
-
Resumen: SBC Medical publica sus resultados financieros del cuarto trimestre y del ejercicio 2025
IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) («SBC Medical» o la «Empresa»), una organización de servicios de gestión que opera una amplia cartera de franquicias en diversos campos médicos, ha anunciado hoy sus resultados financieros correspondientes al cuarto trimestre del ejercicio fiscal 2025 (tres meses concluidos el 31 de diciembre de 2025) y al ejercicio fiscal completo 2025 (doce meses finalizados el 31 de diciembre de 2025). Aspectos destaca...
-
Samenvatting: SBC Medical maakt de financiële resultaten bekend van het vierde kwartaal en het volledige boekjaar 2025
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” of het “Bedrijf”), een Management Services Organization die actief is in een grote verscheidenheid aan franchiseactiviteiten in diverse medische domeinen, maakte vandaag haar financiële resultaten bekend voor het vierde kwartaal van boekjaar 2025 (drie maanden die op 31 december 2025 afliepen) en voor het volledige boekjaar 2025 (twaalf maanden die op 31 december 2025 afliepen). Belangrijkste p...
-
Axway wird im IDC MarketScape: Worldwide API Management 2026 Vendor Assessment als Leader eingestuft
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Axway, ein Unternehmen der 74Software-Gruppe (Euronext: 74SW) und weltweit führender Anbieter im Bereich des föderierten API-Managements und der Unternehmensintegration, wurde im IDC MarketScape: Worldwide API Management 2026 Vendor Assessment als Leader ausgezeichnet.1 Axway Amplify verbindet, koordiniert und automatisiert die Datenintegration auf sichere Weise. Unternehmen aus den Bereichen Finanzdienstleistungen, Fertigung, Gesundheitswesen und anderen Bra...
-
Magellan Aerospace Corporation Announces Financial Results
TORONTO--(BUSINESS WIRE)--Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the fourth quarter of 2025. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are summarized as follows: Three month period ended December 31 Twelve month period ended December 31 Expressed in thousands of Canadian dollars, except per share amounts 2025 2024 Change 2025 2024 Change Revenues 278,325 240,704 15.6% 1,044,682 942,368...
-
Retractable Technologies, Inc. Reports Results for 2025
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company’s revenues for 2025 increased 15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximat...
-
Securities Fraud Investigation Into ImmunityBio, Inc. (IBRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON IMMUNITYBIO, INC. (IBRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 24, 2026, Bloomberg reported that ImmunityBio had receiv...
-
Covalon Announces Grant of Deferred Share Units
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the Company has granted an aggregate of 97,674 Deferred Share Units (“DSUs”) to four of its non-employee directors that elected to receive all or a portion of their annual directors’ fees for fiscal year 2026 in DSUs as opposed to cash. The DSUs were granted under the Company's Amended and Restated Omnibus Long-Term...
-
IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) and reminds investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm...
-
The Fairholme Focused Income Fund Announces Dividend
MIAMI--(BUSINESS WIRE)--On March 27, 2026, the Fairholme Focused Income Fund (“FOCIX” or the “Fund”) distributed an Ordinary Income dividend of $0.07347 per share to shareholders of record as of March 26, 2026. The Fund’s Net Asset Value (“NAV”) was reduced by the amount of the distribution. The Record Date, Ex-Dividend Date, Payable Date, and Cents-Per-Share are as follows: THE FAIRHOLME FOCUSED INCOME FUND Distribution Type Record Date Ex-Dividend Date Payable Date Cents-Per-Share Ordinary...